{
    "clinical_study": {
        "@rank": "16477", 
        "arm_group": [
            {
                "arm_group_label": "Fibroblast Treatment", 
                "arm_group_type": "Experimental", 
                "description": "The fibroblast treatment will be randomly injected into one side of the face."
            }, 
            {
                "arm_group_label": "Vehicle", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The vehicle will be injected randomly to the other side of the face."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to find out if autologous (your own) fibroblast injections are\n      effective for the treatment of acne scars and wrinkles."
        }, 
        "brief_title": "Collagen Injections for the Treatment of Acne Scars and Wrinkles", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Acne Scars", 
            "Wrinkles"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Acne Vulgaris", 
                "Cicatrix"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18 or over\n\n          -  Bilateral acne scars or have moderate to severe wrinkles\n\n          -  Subjects in good health\n\n          -  Subjects has the willingness and the ability to understand and provide informed\n             consent for the use of their tissue and communicate with the investigator\n\n        Exclusion Criteria:\n\n          -  Under 18 years of age\n\n          -  Pregnancy or lactation\n\n          -  recent Accutane use in the past 6 months\n\n          -  prone to hypertrophic and keloidal scarring\n\n          -  have excessively redundant skin in the treatment area or wrinkles longer than 20 cm\n             total\n\n          -  have a history of autoimmune disorders, organ transplantation, cancer not in\n             remission, active or chronic skin disease\n\n          -  have a history of basal-cell carcinoma\n\n          -  have previously received autologous fibroblast treatment\n\n          -  have undergone any confounding therapy in the lower two-thirds of the face within 1\n             year or any investigational treatment within 30 days.\n\n          -  have an allergy to collagen, bovine products, local anesthetics, gentamicin, or\n             amphotericin B\n\n          -  subjects who are unable to understand the protocol or to give informed consent\n\n          -  subjects with mental illness"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01704209", 
            "org_study_id": "STU67333"
        }, 
        "intervention": [
            {
                "arm_group_label": "Fibroblast Treatment", 
                "intervention_name": "Fibroblast Treatment", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Vehicle", 
                "intervention_name": "Vehicle", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "July 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60611"
                }, 
                "name": "Northwestern University Feinberg School of Medicine, Department of Dermatology"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pilot Study of Autologous Fibroblast Injection for Acne Scars, Forehead Lines, Lip Lines, Horizontal Neck Lines, and Static Crow's Feet", 
        "overall_official": {
            "affiliation": "Northwestern University", 
            "last_name": "Murad Alam, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline of rater's comparisons at 6 months", 
            "safety_issue": "No", 
            "time_frame": "Basline and 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01704209"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Northwestern University", 
            "investigator_full_name": "Murad Alam", 
            "investigator_title": "Professor in Dermatology, Otolaryngology- Head and Neck Surgery and Surgery-Organ Transplantation", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Northwestern University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Northwestern University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}